Publications 1996

 

Aboulker JP. The place of the protease inhibitors in antiretroviral combination therapy. Current Opinion in Infectious Disease. Rapid Science Publishers 1996, 9 : 19-22.

Dormont J, Brun-Vézinet F, Yeni P, Aboulker JP.Les antirétroviraux. Médecine Thérapeutique avril 1996, vol. 2 : hors série.


Joly V, Aubry P, Ndayiragide A, Carrière I, Kawa E, Mlika-Cabanne N, Aboulker JP, Coulaud JP, Larouzé B, Yeni P. Randomised comparison of fungizone dissolved in glucose intralipid for the treatment of AIDS-associated cryptococcal meningitis. Clinical Infectious Diseases 1996, 23 : 556-562. Lien PubMed

Delta Coordinating Committee. Delta : A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV infected individuals.
The Lancet 1996, 348 : 283-291.Lien PubMed

Alpha International Coordinating Committee. The Alpha trial : European/Australian randomized double-blind trial of two doses of didanosine in zidovudine-intolerant patients with symptomatic HIV Disease.
AIDS 1996, 10 : 867-80.Lien PubMed

Aboulker JP. Surrogate Markers in AIDS Clinical Trials. Proceedings of the International Falk Workshop, Basel, Switzerland, october 23-24, 1995. Kluwer Academic Publishers, 1996.


Flandre Ph. On the use of auxiliary data to estimate the survival function and its variance : An application to AIDS. J. Clin. Epidemiol. 1996, 49 : 899-905. Lien PubMed